Volume 31, Supplement—May 2025
SUPPLEMENT ISSUE
Supplement
Nationwide Implementation of HIV Molecular Cluster Detection by Centers for Disease Control and Prevention and State and Local Health Departments, United States
Table 2
Number of HIV molecular clusters detected each year through nationwide analysis of National HIV Surveillance System data by Centers for Disease Control and Prevention, United States, 2018-2023*
Characteristics | 2018 | 2019 | 2020† | 2021 | 2022 | 2023 | Total no. |
---|---|---|---|---|---|---|---|
National priority clusters detected‡ |
69 |
74 |
48 |
61 |
77 |
75 |
404 |
Clusters meeting national priority criteria as of December 2023‡ |
2 (3) |
8 (11) |
5 (10) |
9 (15) |
10 (13) |
40 (53) |
74 (18) |
Median cluster size when first detected (range) |
7 (3–24) |
8 (3–19) |
8 (3–16) |
7 (4–18) |
7 (3–14) |
7 (3–23) |
7 (3–24)§ |
Median cluster size as of December 2023 (range) |
17 (3–193) |
17.5 (3–90) |
20 (3–49) |
16 (6–72) |
11 (3–47) |
9 (3–26) |
13 (3–193)§ |
Clusters involving >1 jurisdiction as of December 2023 |
58 (84) |
62 (84) |
43 (90) |
51 (84) |
56 (73) |
55 (73) |
325 (80) |
Clusters with no primary jurisdiction at detection |
6 (9) |
9 (12) |
4 (8) |
5 (8) |
5 (6) |
6 (8) |
35 (9) |
Jurisdictions with >1 cluster as the primary jurisdiction at detection¶ |
25 |
25 |
25 |
20 |
26 |
28 |
43# |
Jurisdictions with >1 cluster with substantial involvement** |
NA |
NA |
NA |
NA |
27 |
31 |
NA |
Clusters with no jurisdiction ever substantially involved |
NA |
NA |
NA |
NA |
2 (3) |
5 (7) |
NA |
Clusters with only 1 jurisdiction ever substantially involved |
NA |
NA |
NA |
NA |
68 (88) |
67(89) |
NA |
Clusters with >2 jurisdictions ever substantially involved | NA | NA | NA | NA | 7 (9) | 3 (4) | NA |
*Values are no. (%) except as indicated. NA, not applicable. †National cluster detection was not conducted for the March 2020 quarter because of disruptions related to the COVID-19 pandemic. ‡National priority clusters are defined as clusters at the 0.5% genetic distance threshold with >5 diagnoses in the previous 12 months or >3 diagnoses in the previous 12 months in low-burden jurisdictions (those having <200 reported HIV diagnoses annually). National priority criteria is assessed on an ongoing basis. §Overall median and range. ¶Primary jurisdiction is defined as the jurisdiction in which >50% of cluster members resided at the time of HIV diagnosis. If there is no single jurisdiction in which >50% of cluster members reside at diagnosis, no primary jurisdiction is assigned. #Total number of unique jurisdictions. **Substantial involvement in national priority clusters is defined as >3 diagnoses in a given jurisdiction (resident at diagnosis or current resident) in the previous 12 months. Multiple jurisdictions can be substantially involved in a cluster at the same time.
1These first authors contributed equally to this article.